Qube Research & Technologies (QRT)’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5	Closed	-$20	–	4935
2023 Q3	$20	Buy	+5	New	+$37	﹤0.01%	3885
2022 Q4	–	Sell	-1,489	Closed	-$14K	–	3151
2022 Q3	$14K	Sell	1,489 -191	-11%	-$3.56K	﹤0.01%	2337
2022 Q2	$32K	Buy	+1,680	New	+$43.5K	﹤0.01%	2201
2021 Q4	–	Sell	-4,490	Closed	-$355K	–	3108
2021 Q3	$355K	Sell	4,490 -913	-17%	-$91.8K	﹤0.01%	1406
2021 Q2	$749K	Buy	+5,403	New	+$1.03M	0.01%	1065

Other funds holding HARP

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HARP Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2023, closing a stake of 5 shares — an estimated $20 sold.

Qube Research & Technologies (QRT) first reported a position in HARP in Q2 2021 and held it in 5 quarters. The position peaked at $749K in Q2 2021. 41 funds tracked by Wall St. Rank hold HARP as of Q4 2023.

Qube Research & Technologies (QRT) reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 5 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $20.
Qube Research & Technologies (QRT) first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Qube Research & Technologies (QRT)'s Harpoon Therapeutics, Inc. Common Stock position peaked at $749K in Q2 2021.
41 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.